The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
20 categories

Pharmacology

Receptor biology, pharmacokinetics and formulation chemistry — the mechanistic layer under everything else.

50 topics2,108 posts5 solved Moderators: dr_okonkwo, KLindqvist About this category

50 topics · page 1 of 2

TopicParticipantsRepliesViewsActivity
About the Receptor biology category
GLP-1, GIP, glucagon and amylin receptor signalling, bias, desensitisation and central versus peripheral action. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
OBDOSOIKP+6 10 34k 20d
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
KTVSMNARF 4 32k 8mo
About the Formulation chemistry category
Buffers, pH, isotonicity, preservatives, lyophilisation and excipient function. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
HSBNKBVTRF 4 4.5k 18mo
Glucagon receptor agonism in a weight-loss compound
On the subject in the title: Glucagon receptor agonism in a weight-loss compound Working notes rather than a conclusion. Posting the method first, because I know what the first three replies will otherwise…
OBLMJM 2 5.1k 20mo
Receptor desensitisation as a tolerance hypothesis, and its weak evidence
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
MAVSOVSKMP+52 57 25k just now
Coming back to: Solubility limits and what a cloudy solution is telling you
On the subject in the title: Solubility limits and what a cloudy solution is telling you Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in…
MMJTVKSSVS+38 43 29k 13h
GIP receptor agonism and the argument about direction — does this still hold?
GIP receptor agonism and the argument about direction — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic…
HMBNSCPWEL+10 14 15k 16h
Solubility limits and what a cloudy solution is telling you
Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate…
SISSVKYRVS+11 15 34k 20h
GLP-1 receptor distribution: central and peripheral
Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…
KHBPJNNSNH+90 98 30k 22h
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means…
CTRSWAVUC+57 61 708 1d
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the first three replies will…
MSPMAICLAP+104 110 16k 2d
Preservatives: function, testing, and limits — one year on
On the subject in the title: Preservatives: function, testing, and limits — one year on Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. tirzepatide…
SDKBBHKHA+28 32 437 8d
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
SMVNICPAJH+58 64 9.7k 2mo
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
BAWADAKLS+11 15 43k 2mo
Amylin receptor signalling and satiety — what changed since
On the subject in the title: Amylin receptor signalling and satiety — what changed since Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in…
GCCNRCBPB+73 78 3.5k 2mo
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
AWBWCEAWS+128 139 3k 3mo
Follow-up: Lyophilisation and why the cake looks the way it does
Lyophilisation and why the cake looks the way it does Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
STVTKBFLC+10 14 11k 3mo
GLP-1 receptor distribution: central and peripheral — one year on
GLP-1 receptor distribution: central and peripheral — one year on — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
GRECSVTTTV+7 11 43k 3mo
[2026 update] Buffers, pH and why a formulation is a formulation
Posting this under the heading it deserves: Buffers, pH and why a formulation is a formulation Everything below is what sits behind that. Working through the identity arithmetic and I would like it checked.…
PDRRS 2 773 3mo
Coming back to: Half-life, steady state, and accumulation worked through
On the subject in the title: Half-life, steady state, and accumulation worked through Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. semaglutide…
CRHKASMISC+14 18 15k 3mo
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
EDRFCHLIAK+110 126 14k 4mo
Adsorption to container surfaces and to plastics
On the subject in the title: Adsorption to container surfaces and to plastics Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of…
CTSOCWRMML+13 17 4.3k 5mo
Lyophilisation and why the cake looks the way it does
Posting this under the heading it deserves: Lyophilisation and why the cake looks the way it does Everything below is what sits behind that. I would like to understand what this number means before I repeat…
DNELBATPKK+33 37 60k 6mo
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long version
Posting this under the heading it deserves: Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long version Everything below is what sits behind that. I would like to understand…
LRAAEVDMA+57 63 1k 6mo
Follow-up: Glucagon receptor agonism in a weight-loss compound
Glucagon receptor agonism in a weight-loss compound Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
AMHNDNLAMD+5 9 21k 7mo
Revisiting: GLP-1 receptor distribution: central and peripheral
Revisiting: GLP-1 receptor distribution: central and peripheral — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
RTHFDTIBRM+61 66 15k 8mo
Follow-up: Why appetite effects are mostly central
Asking directly, because I could not find a straight answer: Why appetite effects are mostly central A documentation question rather than an analytical one. I have a certificate in front of me that reports a…
CRRWMHKMN+86 90 61k 9mo
Amylin receptor signalling and satiety
Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a certificate in front…
SGBCTNNATT+22 26 1.8k 9mo
Follow-up: Subcutaneous absorption kinetics and site differences
Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere. A…
HCFPNVBICM 4 9.9k 10mo
Washout: how long is long enough, and for what purpose
Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
BBNKPABRE+63 70 13k 10mo